Search

everythinglearnresearchcommunity

for

Search:↓

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Baricitinib is effective for severe alopecia areata with manageable side effects, mainly upper respiratory infections.

Applying certain inhibitors to the skin can promote hair growth without harming cells.

Baricitinib effectively promotes hair regrowth in severe alopecia with minimal side effects.

Targeted drug delivery to pancreatic beta-cells can improve type 2 diabetes treatment.

Cedrol nanoemulsions effectively treat hair loss by promoting hair growth and reducing DHT levels safely.

Dutasteride is more effective than finasteride for hair growth with similar side effects.

Wedelolactone may help treat inflammation, infections, cancer, bone loss, and organ damage.

Cedrol may help reduce liver fat and fat cell growth caused by corticosteroids.

Familial dyskeratotic comedones are a rare, inherited skin condition that is hard to treat but may improve slightly with topical retinoids and urea cream.

Baricitinib effectively improved skin and hair conditions in a patient with alopecia areata and atopic dermatitis.

Topical tofacitinib may help regrow hair in children with alopecia totalis.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

The serum reduced thigh fat and improved skin firmness.

GI197111X is best dissolved in Capmul MCM for trials.

Sebum helps protect human skin from microbes.

Deuruxolitinib effectively regrows hair in adults with alopecia areata and is well tolerated.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

A multi-drug treatment can effectively clear extensive calcinosis in juvenile dermatomyositis.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Tianeptine may help prevent hair loss by promoting hair growth and reducing cell death.

New treatments for Dissecting cellulitis show promise, but more research is needed to understand the disease and establish a standard treatment plan.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Metformin may improve acanthosis nigricans by reducing insulin resistance.

CYLD deficiency in skin tumors disrupts hair follicle cell processes and protein secretion.